Disruptive Forces Reshaping Australia’s Healthcare System, with Consequences for Hospitals, Physicians, and Clinical Pathology Laboratories, Outlined at First Annual ‘Disruption in Healthcare Conference’

Topics discussed ranged from ongoing cutbacks in funding for healthcare services, and integration of clinical care to growing use of genetic testing in support of precision medicine DATELINE: Sydney, NSW, Australia—There were 200 leaders in healthcare, medicine, and pathology gathered here last Wednesday to explore a hot topic: the unfolding disruption to healthcare in Australia. The themes of the conference will be familiar to Dark Daily readers across the globe. These themes included: •...

China’s Genome-Mapping Giant BGI Is Poised to Become an International Leader in Gene Sequencing and May Play Major Role in Interpretation of Genetic Test Results

However, China has a shortage of well-trained pathologists, which is why some American lab organizations are establishing medical lab testing ventures in China If experts are right, a company in China is poised to become the world’s largest at gene sequencing. In addition, the huge volume of genetic data it generates is expected to give this company the world’s largest database of genetic information. Such developments could mean that, in just a few years, many pathologists and molecular...

The Scientist’s Top 10 Scientific Innovations for 2014 Offer Powerful New Research Tools to Advance Diagnostics and Possibly Find Uses in Clinical Laboratories

Many of these new technologies could help pathologists develop new diagnostic tests and offer medical laboratories opportunities to expand their services Pathologists and clinical laboratory scientists tracking the hottest new diagnostic technologies may be in interested in the 2014 list of “Top Ten Innovations” recently published by The Scientist. This is a competition and each year The Scientist has a panel of five experts in life sciences review the entries. Among this year’s Top Ten...

J. Craig Venter Joins Race to Crack the Puzzle of Human Aging with New Company That Aims to Sequence 100,000 Human Genomes Yearly

Big Data will play major role as Venter’s team sets out to build world’s largest database of human genotypes, microbiomes and phenotypes For the second time in recent months, another prominent figure has declared his intention to crack the code of human aging. This time it is scientist and entrepreneur J. Craig Venter, Ph.D., known for his role in sequencing the first whole human genome. Venter will pursue this goal through a brand new company he launched, called Human Longevity, Inc. (HLI),...

Is Illumina’s $1,000 Genome a Realty? Not for Clinical Laboratory Purposes, Asserts an In Vitro Diagnostics Expert

Gene sequencing for clinical purposes requires more resources, including the costs of experts to interpret data to help pathologists and physicians involved in the case It was January when headlines nationwide trumpeted Illumina’s introduction of the $1,000 genome. The story in Forbes Magazine, “The $1,000 Genome Arrives—For Real, This Time,” was typical of much of the press coverage. Because pathology groups and clinical laboratories have much at stake in the race to the $1,000 whole-human...